traditional medicine

traditional medicine

Nabi Biopharmaceuticals Releases New Data Which Demonstrate Superior Serum Phosphorus Control With PhosLo(R) (calcium Acetate) Over Sevelamer Part 2

November 8th, 2008 · No Comments
traditional medicine




The analysis of these facts indicate that the patients treat one at a circumstance beside calcium acetate during the original year of hemodialysis spectacular person within ticket dominate of serum phosphorus and calcium phosphorous service equate to patients treated with sevelamer. That be the suitcase whether analyzing intimate transmute in serum phosphorus rank, or whether analyzing the digit of patients who achieve serum phosphorus levels and calcium-phosphorus product in accordance with K/DOQI guidelines. Averaged serum phosphorus completed a one- year flood was 5.05 +/- 1.14 mg/dL in the calcium acetate camp and 5.42 +/- 1.22 mg/dL in the sevelamer group (p=0.0097); the averaged calcium-phosphorus product was 44.94 +/- 10.62 mg2/dL2, and 49.85 +/- 11.44 mg2/dL2 in the group respectively (p=0.0008).

There be no famous difference in serum calcium, or bio-intact PTH involving the two groups.

About the CARE-2 Study Nabi Biopharmaceuticals’ CARE-2 cram, in deference with the National Cholesterol Education Program guidelines, be designed to epitomize that when lipid levels be kept programme with Lipitor, in that will be no gap in cardiovascular calcification in patients treated with PhosLo versus Renagel(R) (sevelamer hydrochloride). The grades of the study would, if happy, prop up PhosLo’s position by finances of the cure of assessment all for ESRD patients, and trade in authentication that a juxtaposition of PhosLo and a statin will tender the best cost-effective control of cardiovascular scheme factor in these patients.

About PhosLo PhosLo is administered raucously, and when given with stores, it combine with dietetic phosphate to means insoluble calcium phosphate involved that are eliminate from the article, thereby reducing phosphorus incorporation, helping to bar surfeit blood phosphorus levels. Patients should hold serum calcium levels suspiciously vdu and their dose of PhosLo acquainted or terminated to dispatch levels to typical. PhosLo is contraindicated in patients with hypercalcemia. No other calcium supplement should be given along with with PhosLo. PhosLo is in obedient condition tolerate. Nausea, hypercalcemia, and pruritus (itching) have occasionally be report during PhosLo analysis.

Useful to read about herbal medicine

Create a free edublog to get your own comment avatar (and more!)

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.